Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Neurological Research|April 8, 2017
Neuroprotective effect of melatonin on soluble Aβ<sub>1-42</sub>-induced cortical neurodegeneration via Reelin-Dab1 signaling pathwayChunli Hu, Pan Wang, Shuman Zhang, et al.
Microbiologyopen|November 19, 2018
Establishment of a highly efficient conjugation protocol for Streptomyces kanamyceticus ATCC12853Shuman Zhang, Tiansheng Chen, Jia Jia, et al.
Frontiers in Cell and Developmental Biology|September 5, 2022
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancerDuo Yun, Zhirong Yang, Shuman Zhang, et al.
Dalton Transactions (Cambridge, England : 2003)|April 7, 2025
A difunctional Dy(III) complex exhibiting single-molecule magnet behaviour and fluorescent cellular imagingXuelian Wang, Zhaopeng Zeng, Mengyuan Li, et al.
Scientific Reports|September 25, 2019
First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involvedShuang Zhao, Shuman Zhang, Weiwei Zhang, et al.
Cancers|October 14, 2023
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic CancerJinping Zhang, Shuman Zhang, Isabella Dörflein, et al.
Cancers|January 8, 2023
Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial MediatorHang He, Shuman Zhang, Hai Yang, et al.
Oncology Letters|April 5, 2019
TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosisSuxia Wu, Weihua Li, Zhenghui Wu, et al.
Cancers|January 21, 2022
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic CancerBin Lan, Siyuan Zeng, Shuman Zhang, et al.
Cancers|October 16, 2025
Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. <i>Cancers</i> 2022, <i>14</i>, 326Bin Lan, Siyuan Zeng, Shuman Zhang, et al.
Pageof 4